As of 2024-12-15, the EV/EBITDA ratio of Paratek Pharmaceuticals Inc (PRTK) is -7.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTK's latest enterprise value is 343.47 mil USD. PRTK's TTM EBITDA according to its financial statements is -44.39 mil USD. Dividing these 2 quantities gives us the above PRTK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.5x - 10.0x | 8.6x |
| Forward P/E multiples | 13.1x - 19.0x | 16.2x |
| Fair Price | (13.92) - (11.51) | (13.36) |
| Upside | -724.3% - -615.9% | -699.3% |
| Date | EV/EBITDA |